| Literature DB >> 2308145 |
D A Holt1, M A Levy, H J Oh, J M Erb, J I Heaslip, M Brandt, H Y Lan-Hargest, B W Metcalf.
Abstract
A series of unsaturated steroids bearing a 3-carboxy substituent has been prepared and assayed in vitro as inhibitors of human and rat prostatic steroid 5 alpha-reductase (EC 1.3.1.30). It is proposed that the observed tight binding of the 3-androstene-3-carboxylic acids is due to mimicry of a putative, high-energy, enzyme-bound enolate intermediate formed during the NADPH-dependent conjugate reduction of testosterone by steroid 5 alpha-reductase. These compounds were prepared through palladium(0)-catalyzed carbomethoxylations of enol (trifluoromethyl)sulfonates derived from 3-keto precursors. Modification of A and B ring unsaturation and substitution at C-3, -4, -6, and -11 was explored. Mono- and dialkylcarboxamides were employed as 17 beta side chains to enhance inhibitory activity with the human enzyme.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2308145 DOI: 10.1021/jm00165a010
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446